In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target

Robert T. Manguso(Broad Institute), Hans W. Pope(Broad Institute), Margaret D. Zimmer(Broad Institute), Flavian D. Brown(Harvard University), Kathleen B. Yates(Massachusetts Institute of Technology), Brian C. Miller(Massachusetts Institute of Technology), Natalie B. Collins(Massachusetts Institute of Technology), Kevin Bi(Dana-Farber Cancer Institute), Martin W. LaFleur(Dana-Farber Cancer Institute), Vikram R. Juneja(Harvard University), Sarah A. Weiss(Dana-Farber Cancer Institute), Jennifer A. Lo(Harvard University), David E. Fisher(Massachusetts General Hospital), Diana Miao(Harvard University), Eliezer M. Van Allen(Harvard University), David E. Root(Broad Institute), Arlene H. Sharpe(Boston Children's Hospital), John G. Doench(Massachusetts Institute of Technology), W. Nicholas Haining(Dana-Farber Cancer Institute)
Nature
July 1, 2017
Cited by 1,141

Abstract


Related Papers

No related papers found

Powered by citation graph analysis